The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

CHATHAM, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Nasal Spray Flu Vaccine Candidate Shows Promise ... in unpasteurized milk is stable on metal and rubber components of commercial milking equipment for at least one hour, increasing its potential ...

9, 2024 — A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration ... components of commercial milking ...

Exercise can lead to rhinitis (nasal inflammation) symptoms, such as sneezing, a runny nose, nasal congestion, or an itchy nose. Two common forms of rhinitis that can lead to a runny nose when ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical ...

Typically, the effect of ketamine tends to wear off within seven days and Spravato – currently the only FDA-approved NMDA receptor antagonist for depression - is administered as a nasal spray ...